Expression and Significance of Hypoxia Inducible Factor-1α and Lysyl Oxidase in Non-small Cell Lung Cancer |
Ping, Wei
(Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Jiang, Wen-Yang (Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) Chen, Wen-Shu (Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) Sun, Wei (Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) Fu, Xiang-Ning (Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology) |
1 | al-Kattan K, Sepsas E, Fountain SW, et al (1997). Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg, 12, 380-4. DOI ScienceOn |
2 | Albinger-Hegyi A, Stoeckli SJ, Schmid S, et al (2010). Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). Int J Cancer, 126, 2653-62. |
3 | Bachtiary B, Schindl M, Potter R, et al (2003). Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res, 9, 2234-40. |
4 | Baker AM, Bird D, Lang G, et al (2013). Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene, 32, 1863-8. DOI ScienceOn |
5 | Birner P, Schindl M, Obermair A, et al (2000). Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res, 60, 4693-6. |
6 | Cheng JC, Klausen C, Leung PC (2013). Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Lett, 329, 197-206. DOI ScienceOn |
7 | Erler JT, Bennewith KL, Nicolau M, et al (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440, 1222-6. DOI ScienceOn |
8 | Gao Y, Xiao Q, Ma H, et al (2010). LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci USA, 107, 18892-7. DOI ScienceOn |
9 | Giatromanolaki A, Koukourakis MI, Sivridis E, et al (2001). Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer, 85, 881-90. DOI ScienceOn |
10 | Gu CD, Osaki T, Oyama T, et al (2002). Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Ann Surg, 235, 133-9. DOI ScienceOn |
11 | Hiraki M, Kitajima Y, Kai K, et al (2012). Knockdown of hypoxia-inducible factor-1alpha accelerates peritoneal dissemination via the upregulation of MMP-1 expression in gastric cancer cell lines. Exp Ther Med, 4, 355-62. |
12 | Hirami Y, Aoe M, Tsukuda K, et al (2004). Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxiainducible factor-1alpha in non-small cell lung cancers. Cancer Lett, 214, 157-64. DOI ScienceOn |
13 | Hung JJ, Yang MH, Hsu HS, et al (2009). Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax, 64, 1082-9. DOI ScienceOn |
14 | Lapointe J, Li C, Higgins JP, et al (2004). Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA, 101, 811-6. DOI ScienceOn |
15 | Lee CH, Lee MK, Kang CD, et al (2003). Differential expression of hypoxia inducible factor-1 alpha and tumor cell proliferation between squamous cell carcinomas and adenocarcinomas among operable non-small cell lung carcinomas. J Korean Med Sci, 18, 196-203. 과학기술학회마을 DOI ScienceOn |
16 | Le QT, Kong C, Lavori PW, et al (2007). Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys, 69, 167-75. DOI ScienceOn |
17 | Sahlgren C, Gustafsson MV, Jin S, et al (2008). Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA, 105, 6392-7. DOI ScienceOn |
18 | Park S, Ha SY, Cho HY, et al (2011). Prognostic implications of hypoxia-inducible factor-1alpha in epidermal growth factor receptor-negative non-small cell lung cancer. Lung Cancer, 72, 100-7. DOI ScienceOn |
19 | Payne SL, Hendrix MJ, Kirschmann DA (2007). Paradoxical roles for lysyl oxidases in cancer--a prospect. J Cell Biochem, 101, 1338-54. DOI ScienceOn |
20 | Pez F, Dayan F, Durivault J, et al (2011). The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res, 71, 1647-57. DOI |
21 | Schietke R, Warnecke C, Wacker I, et al (2010). The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem, 285, 6658-69. DOI ScienceOn |
22 | Schito L, Rey S, Tafani M, et al (2012). Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci USA, 109, E2707-16. DOI |
23 | Siegel R, DeSantis C, Virgo K, et al (2012). Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 62, 220-41. DOI |
24 | Siegel R, Ward E, Brawley O, et al (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. DOI |
25 | Stassar MJ, Devitt G, Brosius M, et al (2001). Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer, 85, 1372-82. DOI ScienceOn |
26 | Volm M, Koomagi R (2000). Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res, 20, 1527-33. |
27 | Stewart GD, Nanda J, Brown DJ, et al (2009). NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway. Int J Cancer, 124, 223-32. DOI ScienceOn |
28 | Swinson DE, Jones JL, Cox G, et al (2004). Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer, 111, 43-50. DOI ScienceOn |
29 | Tammali R, Saxena A, Srivastava SK, et al (2011). Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells. J Biol Chem, 286, 24089-100. DOI ScienceOn |
30 | Wei L, Song XR, Sun JJ, et al (2012). Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration. Cancer Biother Radiopharm, 27, 672-7. DOI ScienceOn |
31 | Wilgus ML, Borczuk AC, Stoopler M, et al (2011). Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer, 117, 2186-91. DOI ScienceOn |
32 | Wong CC, Gilkes DM, Zhang H, et al (2011). Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc Natl Acad Sci USA, 108, 16369-74. DOI ScienceOn |
33 | Wong CC, Zhang H, Gilkes DM, et al (2012). Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J Mol Med (Berl), 90, 803-15. DOI |
34 | Woznick AR, Braddock AL, Dulai M, et al (2005). Lysyl oxidase expression in bronchogenic carcinoma. Am J Surg, 189, 297-301. DOI ScienceOn |
35 | Zhong H, De Marzo AM, Laughner E, et al (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 59, 5830-5. |
36 | Zhang JJ, Wu HS, Wang L, et al (2010). Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma. World J Gastroenterol, 16, 2881-8. DOI ScienceOn |
37 | Zhao T, Gao S, Wang X, et al (2012). Hypoxia-inducible factor-1alpha regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene. PLoS One, 7, e43399. DOI |
![]() |